**Core Concept**
Hyperkalemia is a life-threatening condition characterized by elevated serum potassium levels, often requiring immediate management to prevent cardiac arrhythmias. The underlying principle involves understanding the physiological mechanisms and pharmacological interventions that help lower serum potassium levels.

**Why the Correct Answer is Right**
The correct answer is related to the specific treatment options for hyperkalemia, which include insulin, beta-2 agonists, and calcium channel blockers to stabilize cardiac membranes, among others. Each treatment has a distinct mechanism, such as shifting potassium into cells or counteracting the effects of high potassium on the heart.

**Why Each Wrong Option is Incorrect**
**Option A:** Might be incorrect if it represents a treatment that actually lowers potassium levels, such as insulin or glucose administration.
**Option B:** Could be wrong if it's a medication known to decrease serum potassium, like a loop diuretic.
**Option C:** May be incorrect if it's a treatment used in hyperkalemia management, such as calcium gluconate.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that hyperkalemia management involves both immediate stabilization of cardiac membranes and shifting of potassium into cells, as well as longer-term removal of excess potassium from the body.

**Correct Answer:** D. Calcium channel blockers are not typically used for the management of hyperkalemia; instead, calcium is given to stabilize cardiac membranes. **Correct Answer: D.**